The difficulties of clinical trials evaluating therapeutic agents in patients with severe sepsis (Q37953865)

25 August 2017

The difficulties of clinical trials evaluating therapeutic agents in patients with severe sepsis (English)

1 reference

25 August 2017

0 references

5

1 reference

25 August 2017

T C Hall

1

1 reference

25 August 2017

D K Bilku

series ordinal

2

1 reference

25 August 2017

D Al-Leswas

series ordinal

3

1 reference

25 August 2017

C Horst

series ordinal

4

1 reference

25 August 2017

8 November 2011

1 reference

Irish Journal of Medical Science

25 August 2017

1 reference

25 August 2017

181

1 reference

25 August 2017

1

1 reference

25 August 2017

1-6

1 reference

https://scigraph.springernature.com/pub.10.1007/s11845-011-0778-1

25 August 2017

0 references

cites work

Sepsis in European intensive care units: results of the SOAP study.

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

The Surviving Sepsis Campaign: results of an international guideline-based performance improvement program targeting severe sepsis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Evidence-based medicine in the ICU: important advances and limitations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Clinical trials of immunomodulatory therapies in severe sepsis and septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Accidental removal of endotracheal and nasogastric tubes and intravascular catheters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Intensive insulin therapy in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Efficacy and safety of recombinant human activated protein C for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Hydrocortisone therapy for patients with septic shock

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Intensive insulin therapy and pentastarch resuscitation in severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Intensive Care Society's APACHE II study in Britain and Ireland--II: Outcome comparisons of intensive care units after adjustment for case mix by the American APACHE II method

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Clinical Trial Design and Outcomes in Patients with Severe Sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Clinical gram-positive sepsis: does it fundamentally differ from gram-negative bacterial sepsis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Gram-negative sepsis: a dilemma of modern medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Advances in antibacterial therapy against emerging bacterial pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Gram-positive organisms and sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Bacterial toxin-induced cytokine production studied at the single-cell level

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Genetics of host response to malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Withholding and withdrawal of life support from the critically ill.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Sepsis biomarkers: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Sepsis: a new hypothesis for pathogenesis of the disease process

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Predisposition, insult/infection, response, and organ dysfunction: A new model for staging severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Clinical trials for severe sepsis. Past failures, and future hopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Risks and benefits of activated protein C treatment for severe sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11845-011-0778-1

Nosocomial bacteremia in critically ill patients: a multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC)

21 January 2018

1 reference

12 December 2020

Genetic and environmental influences on premature death in adult adoptees

1 reference

12 December 2020

Bench-to-bedside review: sepsis, severe sepsis and septic shock - does the nature of the infecting organism matter?

1 reference

12 December 2020

Dear SIRS, I'm sorry to say that I don't like you

1 reference

12 December 2020

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

1 reference

12 December 2020

How bad are bacteremia and sepsis? Outcomes in a cohort with suspected bacteremia

1 reference

12 December 2020

Genetic influence on cytokine production and fatal meningococcal disease

1 reference

12 December 2020

Predicting outcome in ICU patients. 2nd European Consensus Conference in Intensive Care Medicine

1 reference

12 December 2020

Sepsis syndrome: a valid clinical entity. Methylprednisolone Severe Sepsis Study Group

1 reference

12 December 2020

Choice of bacteria in animal models of sepsis.

1 reference

12 December 2020

Prediction of mortality in febrile medical patients: How useful are systemic inflammatory response syndrome and sepsis criteria?

1 reference

12 December 2020

Influence of alterations in foregoing life-sustaining treatment practices on a clinical sepsis trial. The HA-1A Sepsis Study Group

1 reference

12 December 2020

10.1007/S11845-011-0778-1

Identifiers

DOI

1 reference

25 August 2017

1 reference